0RAA Stock Overview
Safe Orthopaedics SA, a medical technology company, engages in the design, manufacturing, and marketing of sterile implants and single-use sterile surgical instruments for the treatment of spinal surgery.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Safe Orthopaedics SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.063 |
| 52 Week High | €0.086 |
| 52 Week Low | €0.063 |
| Beta | 1.45 |
| 1 Month Change | 0% |
| 3 Month Change | -21.45% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0RAA | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | -1.1% | 0.3% |
| 1Y | n/a | -6.8% | -0.8% |
Return vs Industry: Insufficient data to determine how 0RAA performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how 0RAA performed against the UK Market.
Price Volatility
| 0RAA volatility | |
|---|---|
| 0RAA Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0RAA's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 0RAA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 138 | Pierre Dumouchel | www.safeorthopaedics.com |
Safe Orthopaedics SA, a medical technology company, engages in the design, manufacturing, and marketing of sterile implants and single-use instruments for the treatment of spinal fracture pathologies in France and internationally. The company’s products portfolio includes SteriSpine PS, an all-round kit for the treatment of spinal fractures and degenerative pathologies, as well as essential kit for percutaneous treatment of spinal fractures; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. Safe Orthopaedics SA was founded in 2010 and is headquartered in Éragny-sur-Oise, France.
Safe Orthopaedics SA Fundamentals Summary
| 0RAA fundamental statistics | |
|---|---|
| Market cap | €336.03k |
| Earnings (TTM) | -€6.96m |
| Revenue (TTM) | €5.86m |
0.1x
P/S Ratio0.0x
P/E RatioIs 0RAA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0RAA income statement (TTM) | |
|---|---|
| Revenue | €5.86m |
| Cost of Revenue | €1.76m |
| Gross Profit | €4.11m |
| Other Expenses | €11.07m |
| Earnings | -€6.96m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.62 |
| Gross Margin | 70.06% |
| Net Profit Margin | -118.84% |
| Debt/Equity Ratio | -609.1% |
How did 0RAA perform over the long term?
See historical performance and comparison